Provided by Tiger Fintech (Singapore) Pte. Ltd.

United Therapeutics

301.42
-6.5800-2.14%
Post-market: 301.420.00000.00%16:20 EDT
Volume:335.34K
Turnover:102.14M
Market Cap:13.60B
PE:12.01
High:313.35
Open:308.26
Low:301.23
Close:308.00
Loading ...

United Therapeutics (UTHR) Surpasses Q4 Earnings and Revenue Estimates

Zacks
·
26 Feb

United Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
26 Feb

United Therapeutics Q4 Net Income Increases, Revenue Drops

MT Newswires Live
·
26 Feb

United Therapeutics Q4 2024 GAAP EPS $6.19 Misses $6.27 Estimate, Sales $735.90M Beat $734.74M Estimate

Benzinga
·
26 Feb

BRIEF-United Therapeutics Q4 Revenue USD 735.9 Million Vs. IBES Estimate USD 734.7 Million

Reuters
·
26 Feb

United Therapeutics Q4 Net Income USD 301.3 Million

THOMSON REUTERS
·
26 Feb

United Therapeutics Corp - Q4 EPS $6.19

THOMSON REUTERS
·
26 Feb

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

Business Wire
·
26 Feb

Top Executive Cashes In on United Therapeutics Stock!

TIPRANKS
·
26 Feb

What To Expect From United Therapeutics’s (UTHR) Q4 Earnings

StockStory
·
25 Feb

Seeking Clues to United Therapeutics (UTHR) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Zacks
·
24 Feb

United Therapeutics Corp expected to post earnings of $6.31 a share - Earnings Preview

Reuters
·
24 Feb

United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference

Business Wire
·
24 Feb

United Therapeutics Corporation (UTHR): Among Renaissance Technologies Portfolio’s Top Stock Picks

Insider Monkey
·
24 Feb

Press Release: United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025

Dow Jones
·
19 Feb

United Therapeutics (UTHR): Buy, Sell, or Hold Post Q3 Earnings?

StockStory
·
14 Feb

Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength?

Zacks
·
13 Feb

Ardelyx (ARDX) Earnings Expected to Grow: Should You Buy?

Zacks
·
13 Feb

United Therapeutics: Growth Prospects and Financial Performance Support ‘Buy’ Rating

TIPRANKS
·
13 Feb

United Therapeutics Corporation (UTHR): A Cheap Biotech Stock to Invest In Now

Insider Monkey
·
12 Feb